The Moving Average Convergence Divergence (MACD) for FBT turned positive on October 20, 2026. Looking at past instances where FBT's MACD turned positive, the stock continued to rise in 46 of 50 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on FBT as a result. In 77 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
FBT moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where FBT advanced for three days, in 296 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
FBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for FBT crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
QGEN saw its Momentum Indicator move above the 0 level on October 09, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In 51 of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at 56%.
The Moving Average Convergence Divergence (MACD) for QGEN just turned positive on October 05, 2026. Looking at past instances where QGEN's MACD turned positive, the stock continued to rise in 22 of 40 cases over the following month. The odds of a continued upward trend are 55%.
QGEN moved above its 50-day moving average on October 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where QGEN advanced for three days, in 141 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.
The Aroon Indicator entered an Uptrend today. In 108 of 193 cases where QGEN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QGEN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
QGEN broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.075) is normal, around the industry mean (66.046). P/E Ratio (25.152) is within average values for comparable stocks, (2.422). Projected Growth (PEG Ratio) (1.201) is also within normal values, averaging (3.473). QGEN's Dividend Yield (0.028) is considerably higher than the industry average of (0.002). P/S Ratio (4.255) is also within normal values, averaging (9.775).
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. QGEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QGEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
QGEN | ||
|---|---|---|
OUTLOOK RATING 1..100 | 46 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 65 | |
PRICE GROWTH RATING 1..100 | 39 | |
P/E GROWTH RATING 1..100 | 56 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| FBT | QGEN | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 44% |
| Stochastic ODDS (%) | 1 day ago 83% | 1 day ago 58% |
| Momentum ODDS (%) | 1 day ago 87% | 1 day ago 56% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 55% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 54% |
| TrendMonth ODDS (%) | 1 day ago 83% | 1 day ago 54% |
| Advances ODDS (%) | 1 day ago 87% | 1 day ago 53% |
| Declines ODDS (%) | 10 days ago 79% | 15 days ago 51% |
| BollingerBands ODDS (%) | 1 day ago 89% | 1 day ago 59% |
| Aroon ODDS (%) | N/A | 1 day ago 56% |
A.I.dvisor indicates that over the last year, FBT has been loosely correlated with IQV. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if FBT jumps, then IQV could also see price increases.
| Ticker / NAME | Correlation To FBT | 1D Price Change % | ||
|---|---|---|---|---|
| FBT | 100% | +0.08% | ||
| IQV - FBT | 64% Loosely correlated | +0.61% | ||
| RARE - FBT | 59% Loosely correlated | +0.19% | ||
| CRL - FBT | 58% Loosely correlated | -1.51% | ||
| AGIO - FBT | 57% Loosely correlated | +0.03% | ||
| QGEN - FBT | 55% Loosely correlated | +0.44% | ||
More | ||||
A.I.dvisor indicates that over the last year, QGEN has been loosely correlated with BRKR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if QGEN jumps, then BRKR could also see price increases.
| Ticker / NAME | Correlation To QGEN | 1D Price Change % | ||
|---|---|---|---|---|
| QGEN | 100% | +0.44% | ||
| BRKR - QGEN | 58% Loosely correlated | -3.04% | ||
| BIO - QGEN | 54% Loosely correlated | +0.83% | ||
| RGEN - QGEN | 49% Loosely correlated | -0.72% | ||
| RVTY - QGEN | 46% Loosely correlated | +0.48% | ||
| ALC - QGEN | 45% Loosely correlated | +4.75% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IVSS | 30.48 | 0.45 | +1.48% |
| Applied Finance IVS US SMID ETF (IVSS) | |||
| IBTP | 24.52 | 0.26 | +1.05% |
| iShares iBonds Dec 2034 Term Treasury ETF (IBTP) | |||
| BLDX | 25.21 | 0.22 | +0.89% |
| Impax Global Sustainable Infrastructure ETF (BLDX) | |||
| FJAN | 56.72 | -0.43 | -0.75% |
| FT Vest US Equity Buffer ETF - January (FJAN) | |||
| STBQ | 21.64 | -0.72 | -3.20% |
| Amplify Stablecoin Technology Leaders ETF (STBQ) | |||